Turmeric and Breast Cancer: Should Women on Tamoxifen Really Avoid It?

Many women with breast cancer around the world are being told to avoid turmeric and in doing so, they are missing out on a wealth of well-documented health benefits. This advice stems from the misinterpretation of a single small study. Here is a clear summary of what the evidence actually shows, why the concern about tamoxifen is overstated, and what the science behind curcumin the active yellow pigment in turmeric really tells us.

What makes turmeric beneficial?

Curcumin is the yellow dye that makes up approximately 5% of whole turmeric root. As a phytochemical, it works through several well-established mechanisms: it reduces excess inflammation, improves antioxidant pathways and supports a healthy gut microbiome. These properties explain why regular intake of turmeric and other phytochemical-rich foods has been consistently linked in population studies to lower rates of cancer development, progression and recurrence.

In laboratory research, turmeric has been shown to reduce resistance to tamoxifen in breast cancer cell lines meaning it may actually improve how tamoxifen works rather than diminish it. It also relieves joint stiffness, a common side effect of both menopause and hormonal cancer treatments, by dampening inflammatory processes in joint cartilage.

A study from Japan involving women experiencing menopausal symptoms after cancer treatment found that those given a turmeric-containing supplement YourPhyto reported a 25% improvement in mood and hot flushes compared to those who did not receive it.

So why are women being told to avoid it?

The concern originates from a single non-randomised clinical trial from the Netherlands, published in 2018, involving just 16 patients. In this study, women taking tamoxifen were given very high dose curcumin 3,600 mg alongside high doses of piperine, a compound found in black pepper that is known to directly interfere with drug metabolism. Researchers observed a 5 to 10% reduction in the blood levels of endoxifen, the active metabolite of tamoxifen, depending on participants' genetic profiles. From this, the authors concluded that women with breast cancer should avoid turmeric entirely.

This conclusion was then repeated by breast cancer support groups worldwide and women have been following that advice ever since.

Why the conclusion was misleading

There are several critical flaws in applying this study's findings to everyday turmeric intake.

The dose used in the study was 3,600 mg of extracted curcumin the equivalent of approximately 72 grams of whole turmeric root in a single day. This is not a quantity anyone would realistically consume. Applying findings from this extreme dose to normal dietary levels or standard supplementation is scientifically inappropriate.

The study also included high-dose piperine, which is itself known to interfere with how the liver metabolises drugs including tamoxifen. This confounds the results significantly any effect seen may have been driven by the piperine rather than the curcumin.

Crucially, there is no clinical evidence that a 5 to 10% reduction in endoxifen blood levels actually reduces tamoxifen's effectiveness. Some published studies have demonstrated clinical benefit from tamoxifen at considerably lower doses than those currently prescribed.

Most importantly, the trial did not measure tamoxifen effectiveness as an outcome. Even if endoxifen levels were slightly reduced, the direct anti-cancer properties of curcumin reducing inflammation, modulating oestrogen receptor signalling, and improving gut microbiome function may more than counterbalance any marginal pharmacokinetic effect.

It should also be noted that this data applies only to tamoxifen, not to aromatase inhibitors such as letrozole or anastrozole. Women on aromatase inhibitors have no pharmacological basis to avoid turmeric at all.

What women on tamoxifen should actually avoid

If there is any practical takeaway from this study, it is narrow and specific: women on tamoxifen should avoid supplements containing high-dose isolated curcumin extract combined with piperine. That is a very different recommendation from avoiding turmeric as a food or as part of a balanced phytochemical-rich supplement.

Dietary turmeric whether in cooking or in a supplement that combines whole turmeric with other phytochemical-rich foods is extremely unlikely to have any meaningful effect on tamoxifen blood levels. Supplements such as YourPhyto, which combine whole turmeric with a broad spectrum of other phytochemicals including pomegranate, green tea, broccoli and cranberry, represent precisely this type of formulation and are notably free from piperine.

Clinical evidence supporting YourPhyto in this context

YourPhyto has been evaluated in a large national double-blind randomised trial involving 208 participants, published in European Urology Oncology. Results showed a statistically significant slowing of cancer progression measured on MRI and PSA blood markers. A sub-analysis published in the Journal of Ageing and Longevity reported improvements in urinary symptoms, reduced inflammatory markers, improved grip strength and improved wellbeing. A further randomised trial is now being designed at University College London Hospital (UCLH), combining YourPhyto with the probiotic blend YourGutPlus+ specifically for women experiencing menopausal symptoms whether naturally or induced by hormonal treatments or chemotherapy.

The broader picture

The misinterpretation of one small, heavily confounded study has led to widespread advice that denies women with breast cancer access to one of the most extensively studied anti-inflammatory phytochemicals available. The evidence base for curcumin's benefits including its potential to reduce tamoxifen resistance, relieve joint symptoms, support gut health and reduce systemic inflammation is substantial and continues to grow.

Women on tamoxifen who are concerned about their supplement choices should raise the question with their oncologist, bringing this evidence to the conversation. The answer, in most cases, is that whole-food turmeric intake and phytochemical-rich supplements without piperine are not only safe but potentially beneficial alongside their treatment.

Citation

Scientific Editor (Prof. Robert Thomas, Consultant Breast Cancer Oncologist and Head of Integrative Oncology at UCLH). "Turmeric Tamoxifen Breast Cancer." Keep Healthy, 3 May 2026. Available at: https://keep-healthy.com/turmeric-tamoxifen-breast-cancer/